• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Proteus Digital Health

Pandemic forces Proteus into bankruptcy

June 16, 2020 By Nancy Crotti

Proteus Digital Health updated logo

Proteus Digital Health has filed for Chapter 11 bankruptcy protection, noting that its efforts to raise money or sell the company fell victim to the COVID-19 pandemic. The Redwood City, Calif.-based company missed a $100 million funding target in December. Once valued at $1.5 billion, Proteus previously raised $420 million from investors including Novartis Venture Fund […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Otsuka Pharmaceutical, Proteus Digital Health, Robert Bosch North America, Romaco North America, Xcelience

Proteus Digital Health restructuring amid reported funding woes

December 9, 2019 By Nancy Crotti

Proteus Digital Health updated logo

Proteus Digital Health said today that it is restructuring, reportedly because it failed to close a $100 million funding round. A report by CNBC said the Redwood City, Calif.-based company missed the funding target. Once valued at $1.5 billion, the company previously raised $420 million from investors including Novartis Venture Fund and Kaiser Permanente Ventures, according to an […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Proteus Digital Health

Proteus debuts digital cancer drug

January 17, 2019 By Sarah Faulkner

Proteus Digital Health updated logo

Proteus Digital Health said today that the first cancer patients were treated using its digital oncology therapy, which combines oral chemotherapy with an ingestible sensor. Patients with stage 3 and 4 colorectal cancer at the University of Minnesota Health and Fairview Health Services were treated with digital capecitabine. The Redwood City, Calif.-based company plans to […]

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health), Oncology, Pharmaceuticals Tagged With: Proteus Digital Health

Anthem exec chairman joins Proteus board | Personnel Moves – Feb. 26, 2018

February 26, 2018 By Sarah Faulkner

Proteus Digital Health

Proteus Digital Health announced earlier this month that Anthem‘s (NYSE:ANTM) executive chairman, Joseph Swedish, joined the company’s board of directors. Swedish served as Anthem’s president & chief executive from 2013 until he was appointed executive chairman in 2018. “Proteus has created a compelling solution to a problem that has plagued the pharmaceutical industry for decades: […]

Filed Under: Featured, Personnel, Pharmaceuticals, Wall Street Beat Tagged With: Aerie Pharmaceuticals, Allergan, Anthem, BioCorRx, Brainstorm Cell Therapeutics, Chrono Therapeutics, infusystem, Proteus Digital Health, Reva Medical, zynosolutions

The ‘smart pill’ market could be worth $3B by 2025 – meet the key players

January 4, 2018 By Sarah Faulkner

Pills

The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities. There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: capsovision, etectrx, Medtronic, olympus, Proteus Digital Health

FDA approves first pill with sensor to track ingestion

November 14, 2017 By Sarah Faulkner

Otsuka Pharmaceutical, Proteus Digital Health

The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken. The drug-device combination product is indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes linked with bipolar I disorder and as an […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Neurological, Pharmaceuticals, Regulatory/Compliance, Wall Street Beat Tagged With: Otsuka Pharmaceutical, Proteus Digital Health

Ocular continues personnel shakeup with new CMO | Personnel Moves – Sept. 13, 2017

September 14, 2017 By Sarah Faulkner

Ocular Therapeutix

After Ocular Therapeutix‘s (NSDQ:OCUL) founder & CEO, Amar Swahney, stepped down earlier this year, pharma executive Antony Mattessich stepped in to assume the corner office. He signaled some major changes to the company’s business strategy in a call with analysts last month, including an attempt to ‘aggressively seek new partnerships’ and ‘enhance [the company’s] credibility’. As […]

Filed Under: Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Wall Street Beat Tagged With: Aeterna Zentaris, Bayer AG, Biogen Idec, Eyevensys, lyndra, Mylan, Ocular Therapeutix, Proteus Digital Health, rebiotix, Teva

BioDelivery Sciences president, CEO Sirgo to retire | Personnel Moves – Aug 29, 2017

August 29, 2017 By Sarah Faulkner

BioDelivery Sciences International

BioDelivery Sciences (NSDQ:BDSI) said last week that its president & CEO, Mark Sirgo, plans to retire at the end of this year. Sirgo has held the corner office at the Raleigh, N.C.-based company since 2005. He will stay on as vice chairman of the board and will help determine his successor, BioDelivery Sciences reported. “After thirteen […]

Filed Under: Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Wall Street Beat Tagged With: Aerie Pharmaceuticals, BioDelivery Sciences International, Insulet, Merrimack Pharmaceuticals, Novartis, Ocular Therapeutix, pierispharmaceuticals, Proteus Digital Health, Shire, SteadyMed Therapeutics

Proteus, Otsuka take another run at FDA approval for Abilify-smart pill combo

May 23, 2017 By Sarah Faulkner

Otsuka Pharmaceutical, Proteus Digital Health

Otsuka Pharmaceutical (TYO:4578) and Proteus Digital Health said today that the FDA accepted its resubmitted new drug application for their “smart pill”. The drug-device product combines Abilify and a Proteus ingestible sensor in a single tablet. The FDA is slated to make a decision on the NDA resubmission in the 4th quarter this year. After the […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance Tagged With: Otsuka Pharmaceutical, Proteus Digital Health

FDA wants more from Proteus, Otsuka on 'smart pill'

April 27, 2016 By Fink Densford

Otsuka Pharmaceutical (TYO:4578) and Proteus Digital Health  said today that the FDA issued a complete response letter requesting more information from the companies for the combination of the Proteus “smart pill” and Otsuka’s Abilify anti-depressant drug. The Proteus pill is designed to signal a wearable patch after it reaches the stomach, recording and time-stamping data from […]

Filed Under: Drug-Device Combinations Tagged With: Otsuka Pharmaceutical, Proteus Digital Health

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS